ArticleWorld journal of surgery2026
Worse Prognosis of Patients With Hepatocellular Carcinoma and Portal Vein Invasion Underestimated by Imaging.
Article in World journal of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPortal vein invasion is closely linked to poor prognosis in hepatocellular carcinoma (HCC). However, no study has directly compared preoperative imaging with postoperative histopathological diagnoses of portal vein invasion. This study evaluated the prognostic impact of underdiagnosed portal vein invasion in patients undergoing hepatectomy.
methodsWe retrospectively reviewed 1328 patients who underwent initial hepatectomy for HCC from January 2000 to December 2020. Portal vein invasion was classified as Image-Vp0-4 based on preoperative imaging and vp0-4 based on postoperative pathology. Underdiagnosis was defined as IVp < vp; otherwise, IVp ≥ vp. Gross invasion was defined as vp2-4, and non-gross invasion as vp0/1.
resultsPathological staging stratified overall survival (OS) more clearly than imaging (median OS: vp0 = 7.9 years; vp1 = 5.6; vp2 = 2.5; vp3 = 1.6; vp4 = 0.5), while Image-Vp showed less consistent trends (Vp0-4 = 7.9; 7.6; 9.5; 1.6; 0.5 years). Underdiagnosis occurred most frequently in Image-Vp0 and vp1 cases (16.7%). Patients with IVp < vp had significantly worse OS than those with IVp ≥ vp (5.6 vs. 7.9 years, p < 0.001). Among vp0/1 patients, OS was significantly shorter in underdiagnosed cases (5.8 vs. 7.9 years, p < 0.001), whereas in vp2-4 cases, underdiagnosis had no significant effect (3.9 vs. 1.6 years, p = 0.317).
conclusionsUnderdiagnosis of vp1 was associated with significantly reduced survival in HCC patients, despite negative imaging findings. These results highlight the critical role of postoperative histopathology in accurately assessing portal vein invasion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.